Business
CHM announces positive Phase 1/2 data at ASCO
CHM announces positive Phase 1/2 data at ASCO

About this update from Chimeric Therapeutics Limited
Chimeric Therapeutics Limited has released a press release. View Attachment
View stock analysis, news, and events for Chimeric Therapeutics Limited